Why Some Patients Stop Ketamine Therapy Early

A woman with long hair walks down a sunlit street holding two yellow balloons, town rooftops ahead
Please note that throughout this blog, we may refer to ketamine, esketamine, and Spravato relatively interchangeably. This is due to the inherent similarities in chemical makeup between ketamine and esketamine, and their similar effects on mental health conditions. Don't hesitate to reach out to Lumin Health staff to ask any questions about treatment at hello@lumin.health or by scheduling a free consultation.

Understanding Why Some Patients Stop Ketamine Therapy Early

Ketamine therapy and esketamine (Spravato) treatment offer real hope for many who have not found relief elsewhere. But not every patient continues with treatment long-term — some stop after only a few sessions or weeks. These decisions are not failures but important moments of reflection about what is and isn’t working, both medically and personally. It is important to understand what does not work in the pursuit of what does.  The Lumin Health treatment program is carefully designed to talk with patients about how treatment is going and to be helpful even if treatment is not delivering the hoped-for results.  Our goal is shared: to find a way to improve symptoms.  If ketamine or esketamine isn’t the way forward we will help you find one that is.  

Non-Response to Ketamine / Esketamine

Despite ketamine’s growing promise as a robust and fast-acting treatment for mental health conditions like treatment-resistant depression, not everyone experiences benefit. Some patients may complete six to eight sessions — the point at which clinicians often evaluate effectiveness — without meaningful symptom change. Others may notice small shifts that don’t feel significant enough to continue. In these cases, it’s reasonable to pause. 

Insurance Realities: Getting Ketamine Covered by Insurance

Insurance coverage and cost play a significant role. While Spravato is FDA-approved and usually insurance-covered, IV or intramuscular ketamine is often out-of-pocket. Even with insurance, co-pays and logistical demands can weigh heavily. Some patients discontinue when financial or scheduling barriers become unsustainable. At Lumin Health, these realities are always acknowledged in treatment planning, ensuring that decisions are made with transparency and support.  If cost becomes an issue, we hope that a person feels comfortable enough with our staff to bring it up as we try to work with everyone to generate a program that is sustainable.  

Next Treatment Steps

Discontinuing ketamine therapy does not mean the end of care. Patients who do not continue may:

  • Explore other pharmacological options, including different classes of antidepressants or augmenting agents.
  • Consider non-medication treatments such as transcranial magnetic stimulation (TMS).
  • Re-engage psychotherapy during or after the ketamine trial, making use of any small gains in openness or energy.
  • Revisit ketamine or Spravato in the future, as individual readiness and biology may change over time.

Reflecting on Early Discontinuation of Ketamine at Lumin Health

Stopping ketamine therapy early is not a sign of defeat. For some, it is simply the recognition that this path does not serve them at this time. For others, it opens the door to new approaches. At Lumin Health, we see discontinuation not as the end of the story, but as part of an ongoing process of care. Every patient deserves options, and every decision about treatment deserves respect.

You've read the science. Now take the next step.

Lumin Health provides safe, expert-administered ketamine and Spravato treatment across Massachusetts and the greater Washington DC/Maryland area. Your journey starts with a free, no-commitment intro call.

Available in Massachusetts and the greater Washington DC/Maryland area.

Book a Free Intro Call

Frequently Asked Questions

Why do some patients stop ketamine therapy early?

Some patients complete six to eight sessions, the point where clinicians often evaluate whether treatment is working, without meaningful symptom change. Others notice only small shifts that do not feel significant enough to continue. Cost and scheduling can also play a role, especially for off-label ketamine that is not usually insurance-covered.

Is stopping ketamine treatment a failure?

No, it is a moment of reflection about what is and is not working for you, medically and personally, not a sign of defeat. For some it means this path does not serve them right now, and for others it opens the door to a different approach. Every decision about your treatment deserves respect.

What are the next steps if ketamine therapy does not work for me?

You may explore other medication options, including different classes of antidepressants or augmenting agents, or non-medication treatments such as transcranial magnetic stimulation (TMS). Re-engaging with psychotherapy or your own self-guided practice is another path some people take. You can also revisit ketamine or esketamine (Spravato) later, since readiness and response can change over time.

Does insurance cover ketamine therapy?

Esketamine (Spravato) is FDA-approved and usually covered by insurance, but off-label intramuscular (IM) ketamine is often out-of-pocket. Co-pays and scheduling demands can still add up even with coverage. At Lumin Health, cost and insurance realities are discussed openly as part of treatment planning.

Latest medical review on: September 15th, 2026. Medically reviewed by Instructor in Psychiatry at Harvard Medical School and Lumin Health Co-founder, Chief Medical Officer Dr. Ben Yudkoff.